APO Research
Talk to an analyst

APO RESEARCH · REPORT

Decongestant

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Decongestant Market Analysis and Forecast 2026-2032

31 December 2025197 pages

Choose your research edition.

Industry ResearchDecongestant Industry Research Report 2026115 pages · $2,950 USDIndustry Growth & TrendsGlobal Decongestant Industry Growth and Trends Forecast to 203299 pages · $3,450 USDMarket StructureGlobal Decongestant Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Decongestant Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Decongestant Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Decongestant market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Decongestant is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Decongestant include Teva Pharmaceutical Industries Ltd., Novartis AG, Mylan N.V., Ranbaxy Laboratories Ltd., Cipla Ltd. and Beximco Pharmaceuticals Ltd., etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Decongestant, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Decongestant, also provides the sales of main regions and countries. Of the upcoming market potential for Decongestant, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Decongestant sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Decongestant market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Decongestant sales, projected growth trends, production technology, application and end-user industry.

Decongestant Segment by Company

Teva Pharmaceutical Industries Ltd.

Novartis AG

Mylan N.V.

Ranbaxy Laboratories Ltd.

Cipla Ltd.

Beximco Pharmaceuticals Ltd.

Decongestant Segment by Type

Nasal Sprays

Capsules

Tablets

Decongestant Segment by Application

Research & Academic Laboratories

Hospitals

Clinic

Other

Decongestant Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Decongestant market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Decongestant and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Decongestant.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Decongestant in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Decongestant manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Decongestant sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Decongestant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Nasal Sprays Major Manufacturers Table 3. Capsules Major Manufacturers Table 4. Tablets Major Manufacturers Table 5. Global Decongestant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Research & Academic Laboratories Major Manufacturers Table 7. Hospitals Major Manufacturers Table 8. Clinic Major Manufacturers Table 9. Other Major Manufacturers Table 10. Decongestant Industry Trends Table 11. Decongestant Industry Drivers Table 12. Decongestant Industry Opportunities and Challenges Table 13. Decongestant Industry Restraints Table 14. Global Decongestant Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Decongestant Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Decongestant Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Decongestant Revenue Market Share by Region (2021-2026) Table 18. Global Decongestant Revenue Market Share by Region (2027-2032) Table 19. Global Decongestant Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 20. Global Decongestant Sales by Region (2021-2026) & (K Units) Table 21. Global Decongestant Sales by Region (2027-2032) & (K Units) Table 22. Global Decongestant Sales Market Share by Region (2021-2026) Table 23. Global Decongestant Sales Market Share by Region (2027-2032) Table 24. Global Decongestant Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Decongestant Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Decongestant Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Decongestant Sales Market Share by Manufacturers (2021-2026) Table 28. Global Decongestant Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 29. Global Decongestant Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Decongestant Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Decongestant Manufacturers, Product Type & Application Table 32. Global Decongestant Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Decongestant by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Decongestant Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Decongestant Revenue Market Share by Type (2021-2026) Table 39. Global Decongestant Revenue Market Share by Type (2027-2032) Table 40. Global Decongestant Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 41. Global Decongestant Sales by Type (2021-2026) & (K Units) Table 42. Global Decongestant Sales by Type (2027-2032) & (K Units) Table 43. Global Decongestant Sales Market Share by Type (2021-2026) Table 44. Global Decongestant Sales Market Share by Type (2027-2032) Table 45. Global Decongestant Price by Type (2021-2026) & (US$/Unit) Table 46. Global Decongestant Price by Type (2027-2032) & (US$/Unit) Table 47. Global Decongestant Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Decongestant Revenue Market Share by Application (2021-2026) Table 51. Global Decongestant Revenue Market Share by Application (2027-2032) Table 52. Global Decongestant Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 53. Global Decongestant Sales by Application (2021-2026) & (K Units) Table 54. Global Decongestant Sales by Application (2027-2032) & (K Units) Table 55. Global Decongestant Sales Market Share by Application (2021-2026) Table 56. Global Decongestant Sales Market Share by Application (2027-2032) Table 57. Global Decongestant Price by Application (2021-2026) & (US$/Unit) Table 58. Global Decongestant Price by Application (2027-2032) & (US$/Unit) Table 59. Teva Pharmaceutical Industries Ltd. Company Information Table 60. Teva Pharmaceutical Industries Ltd. Business Overview Table 61. Teva Pharmaceutical Industries Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 62. Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio Table 63. Teva Pharmaceutical Industries Ltd. Recent Development Table 64. Novartis AG Company Information Table 65. Novartis AG Business Overview Table 66. Novartis AG Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Novartis AG Decongestant Product Portfolio Table 68. Novartis AG Recent Development Table 69. Mylan N.V. Company Information Table 70. Mylan N.V. Business Overview Table 71. Mylan N.V. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Mylan N.V. Decongestant Product Portfolio Table 73. Mylan N.V. Recent Development Table 74. Ranbaxy Laboratories Ltd. Company Information Table 75. Ranbaxy Laboratories Ltd. Business Overview Table 76. Ranbaxy Laboratories Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Ranbaxy Laboratories Ltd. Decongestant Product Portfolio Table 78. Ranbaxy Laboratories Ltd. Recent Development Table 79. Cipla Ltd. Company Information Table 80. Cipla Ltd. Business Overview Table 81. Cipla Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Cipla Ltd. Decongestant Product Portfolio Table 83. Cipla Ltd. Recent Development Table 84. Beximco Pharmaceuticals Ltd. Company Information Table 85. Beximco Pharmaceuticals Ltd. Business Overview Table 86. Beximco Pharmaceuticals Ltd. Decongestant Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio Table 88. Beximco Pharmaceuticals Ltd. Recent Development Table 89. North America Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 90. North America Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 91. North America Decongestant Sales by Type (2021-2026) & (K Units) Table 92. North America Decongestant Sales by Type (2027-2032) & (K Units) Table 93. North America Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 94. North America Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 95. North America Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 96. North America Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 97. North America Decongestant Sales by Application (2021-2026) & (K Units) Table 98. North America Decongestant Sales by Application (2027-2032) & (K Units) Table 99. North America Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 100. North America Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 101. North America Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 102. North America Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 103. North America Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 104. North America Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 105. North America Decongestant Sales by Country (2021-2026) & (K Units) Table 106. North America Decongestant Sales by Country (2027-2032) & (K Units) Table 107. North America Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 108. North America Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 109. United States Decongestant Revenue (2021-2032) & (US$ Million) Table 110. Canada Decongestant Revenue (2021-2032) & (US$ Million) Table 111. Europe Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 112. Europe Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 113. Europe Decongestant Sales by Type (2021-2026) & (K Units) Table 114. Europe Decongestant Sales by Type (2027-2032) & (K Units) Table 115. Europe Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 116. Europe Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 117. Europe Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 118. Europe Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 119. Europe Decongestant Sales by Application (2021-2026) & (K Units) Table 120. Europe Decongestant Sales by Application (2027-2032) & (K Units) Table 121. Europe Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 122. Europe Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 123. Europe Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 124. Europe Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 125. Europe Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 126. Europe Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 127. Europe Decongestant Sales by Country (2021-2026) & (K Units) Table 128. Europe Decongestant Sales by Country (2027-2032) & (K Units) Table 129. Europe Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 130. Europe Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 131. Germany Decongestant Revenue (2021-2032) & (US$ Million) Table 132. France Decongestant Revenue (2021-2032) & (US$ Million) Table 133. U.K. Decongestant Revenue (2021-2032) & (US$ Million) Table 134. Italy Decongestant Revenue (2021-2032) & (US$ Million) Table 135. Netherlands Decongestant Revenue (2021-2032) & (US$ Million) Table 136. Nordic Countries Decongestant Revenue (2021-2032) & (US$ Million) Table 137. China Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 138. China Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 139. China Decongestant Sales by Type (2021-2026) & (K Units) Table 140. China Decongestant Sales by Type (2027-2032) & (K Units) Table 141. China Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 142. China Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 143. China Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 144. China Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 145. China Decongestant Sales by Application (2021-2026) & (K Units) Table 146. China Decongestant Sales by Application (2027-2032) & (K Units) Table 147. China Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 148. China Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 149. Asia Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 150. Asia Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 151. Asia Decongestant Sales by Type (2021-2026) & (K Units) Table 152. Asia Decongestant Sales by Type (2027-2032) & (K Units) Table 153. Asia Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 154. Asia Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 155. Asia Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 156. Asia Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 157. Asia Decongestant Sales by Application (2021-2026) & (K Units) Table 158. Asia Decongestant Sales by Application (2027-2032) & (K Units) Table 159. Asia Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 160. Asia Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 161. Asia Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 162. Asia Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 163. Asia Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 164. Asia Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 165. Asia Decongestant Sales by Country (2021-2026) & (K Units) Table 166. Asia Decongestant Sales by Country (2027-2032) & (K Units) Table 167. Asia Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 168. Asia Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 169. Japan Decongestant Revenue (2021-2032) & (US$ Million) Table 170. South Korea Decongestant Revenue (2021-2032) & (US$ Million) Table 171. India Decongestant Revenue (2021-2032) & (US$ Million) Table 172. Australia Decongestant Revenue (2021-2032) & (US$ Million) Table 173. China Taiwan Decongestant Revenue (2021-2032) & (US$ Million) Table 174. Southeast Asia Decongestant Revenue (2021-2032) & (US$ Million) Table 175. SAMEA Decongestant Revenue by Type (2021-2026) & (US$ Million) Table 176. SAMEA Decongestant Revenue by Type (2027-2032) & (US$ Million) Table 177. SAMEA Decongestant Sales by Type (2021-2026) & (K Units) Table 178. SAMEA Decongestant Sales by Type (2027-2032) & (K Units) Table 179. SAMEA Decongestant Sales Price by Type (2021-2026) & (US$/Unit) Table 180. SAMEA Decongestant Sales Price by Type (2027-2032) & (US$/Unit) Table 181. SAMEA Decongestant Revenue by Application (2021-2026) & (US$ Million) Table 182. SAMEA Decongestant Revenue by Application (2027-2032) & (US$ Million) Table 183. SAMEA Decongestant Sales by Application (2021-2026) & (K Units) Table 184. SAMEA Decongestant Sales by Application (2027-2032) & (K Units) Table 185. SAMEA Decongestant Sales Price by Application (2021-2026) & (US$/Unit) Table 186. SAMEA Decongestant Sales Price by Application (2027-2032) & (US$/Unit) Table 187. SAMEA Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. SAMEA Decongestant Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. SAMEA Decongestant Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. SAMEA Decongestant Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. SAMEA Decongestant Sales by Country (2021-2026) & (K Units) Table 192. SAMEA Decongestant Sales by Country (2027-2032) & (K Units) Table 193. SAMEA Decongestant Sales Price by Country (2021-2026) & (US$/Unit) Table 194. SAMEA Decongestant Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Brazil Decongestant Revenue (2021-2032) & (US$ Million) Table 196. Argentina Decongestant Revenue (2021-2032) & (US$ Million) Table 197. Chile Decongestant Revenue (2021-2032) & (US$ Million) Table 198. Colombia Decongestant Revenue (2021-2032) & (US$ Million) Table 199. Peru Decongestant Revenue (2021-2032) & (US$ Million) Table 200. Saudi Arabia Decongestant Revenue (2021-2032) & (US$ Million) Table 201. Israel Decongestant Revenue (2021-2032) & (US$ Million) Table 202. UAE Decongestant Revenue (2021-2032) & (US$ Million) Table 203. Turkey Decongestant Revenue (2021-2032) & (US$ Million) Table 204. Iran Decongestant Revenue (2021-2032) & (US$ Million) Table 205. Egypt Decongestant Revenue (2021-2032) & (US$ Million) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Decongestant Distributors List Table 209. Decongestant Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Decongestant Image Figure 2. Global Decongestant Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Decongestant Market Size Share 2021 VS 2025 VS 2032 Figure 4. Nasal Sprays Image Figure 5. Capsules Image Figure 6. Tablets Image Figure 7. Global Decongestant Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Decongestant Market Size Share 2021 VS 2025 VS 2032 Figure 9. Research & Academic Laboratories Image Figure 10. Hospitals Image Figure 11. Clinic Image Figure 12. Other Image Figure 13. Global Decongestant Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Decongestant Revenue (2021-2032) & (US$ Million) Figure 15. Global Decongestant Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Decongestant Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Decongestant Revenue Market Share by Region (2021-2032) Figure 18. Global Decongestant Sales (2021-2032) & (K Units) Figure 19. Global Decongestant Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 20. Global Decongestant Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Decongestant Sales YoY (2021-2032) & (K Units) Figure 22. Europe Decongestant Sales YoY (2021-2032) & (K Units) Figure 23. China Decongestant Sales YoY (2021-2032) & (K Units) Figure 24. Asia (Excluding China) Decongestant Sales YoY (2021-2032) & (K Units) Figure 25. South America, Middle East and Africa Decongestant Sales YoY (2021-2032) & (K Units) Figure 26. Global Decongestant Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Decongestant Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Decongestant Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Decongestant Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Decongestant Revenue Market Share by Type (2021-2032) Figure 32. Global Decongestant Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 33. Global Decongestant Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Decongestant Sales Market Share by Type (2021-2032) Figure 35. Global Decongestant Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Decongestant Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Decongestant Revenue Market Share by Application (2021-2032) Figure 38. Global Decongestant Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 39. Global Decongestant Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Decongestant Sales Market Share by Application (2021-2032) Figure 41. North America Decongestant Revenue Share by Type (2021-2032) Figure 42. North America Decongestant Sales Share by Type (2021-2032) Figure 43. North America Decongestant Revenue Share by Application (2021-2032) Figure 44. North America Decongestant Sales Share by Application (2021-2032) Figure 45. North America Decongestant Revenue Share by Country (2021-2032) Figure 46. North America Decongestant Sales Share by Country (2021-2032) Figure 47. Europe Decongestant Revenue Share by Type (2021-2032) Figure 48. Europe Decongestant Sales Share by Type (2021-2032) Figure 49. Europe Decongestant Revenue Share by Application (2021-2032) Figure 50. Europe Decongestant Sales Share by Application (2021-2032) Figure 51. Europe Decongestant Revenue Share by Country (2021-2032) Figure 52. Europe Decongestant Sales Share by Country (2021-2032) Figure 53. China Decongestant Revenue Share by Type (2021-2032) Figure 54. China Decongestant Sales Share by Type (2021-2032) Figure 55. China Decongestant Revenue Share by Application (2021-2032) Figure 56. China Decongestant Sales Share by Application (2021-2032) Figure 57. Asia Decongestant Revenue Share by Type (2021-2032) Figure 58. Asia Decongestant Sales Share by Type (2021-2032) Figure 59. Asia Decongestant Revenue Share by Application (2021-2032) Figure 60. Asia Decongestant Sales Share by Application (2021-2032) Figure 61. Asia Decongestant Revenue Share by Country (2021-2032) Figure 62. Asia Decongestant Sales Share by Country (2021-2032) Figure 63. SAMEA Decongestant Revenue Share by Type (2021-2032) Figure 64. SAMEA Decongestant Sales Share by Type (2021-2032) Figure 65. SAMEA Decongestant Revenue Share by Application (2021-2032) Figure 66. SAMEA Decongestant Sales Share by Application (2021-2032) Figure 67. SAMEA Decongestant Revenue Share by Country (2021-2032) Figure 68. SAMEA Decongestant Sales Share by Country (2021-2032) Figure 69. Decongestant Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Decongestant Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Nasal Sprays
  • Capsules
  • Tablets
Applications
  • Research & Academic Laboratories
  • Hospitals
  • Clinic
  • Other
Companies covered
  • Teva Pharmaceutical Industries Ltd.
  • Novartis AG
  • Mylan N.V.
  • Ranbaxy Laboratories Ltd.
  • Cipla Ltd.
  • Beximco Pharmaceuticals Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Decongestant Market by Type
  3. 1.2.1 Global Decongestant Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Nasal Sprays
  5. 1.2.3 Capsules
  6. 1.2.4 Tablets
  7. 1.3 Decongestant Market by Application
  8. 1.3.1 Global Decongestant Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Research & Academic Laboratories
  10. 1.3.3 Hospitals
  11. 1.3.4 Clinic
  12. 1.3.5 Other
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Decongestant Market Dynamics
  1. 2.1 Decongestant Industry Trends
  2. 2.2 Decongestant Industry Drivers
  3. 2.3 Decongestant Industry Opportunities and Challenges
  4. 2.4 Decongestant Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Decongestant Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Decongestant Revenue by Region
  3. 3.2.1 Global Decongestant Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Decongestant Revenue by Region (2021-2026)
  5. 3.2.3 Global Decongestant Revenue by Region (2027-2032)
  6. 3.2.4 Global Decongestant Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Decongestant Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Decongestant Sales by Region
  9. 3.4.1 Global Decongestant Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Decongestant Sales by Region (2021-2026)
  11. 3.4.3 Global Decongestant Sales by Region (2027-2032)
  12. 3.4.4 Global Decongestant Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Decongestant Revenue by Manufacturers
  2. 4.1.1 Global Decongestant Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Decongestant Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Decongestant Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Decongestant Sales by Manufacturers
  6. 4.2.1 Global Decongestant Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Decongestant Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Decongestant Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Decongestant Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Decongestant Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Decongestant Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Decongestant Manufacturers, Product Type & Application
  13. 4.7 Global Decongestant Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Decongestant Market CR5 and HHI
  16. 4.8.2 2025 Decongestant Tier 1, Tier 2, and Tier 3
5 Decongestant Market by Type
  1. 5.1 Global Decongestant Revenue by Type
  2. 5.1.1 Global Decongestant Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Decongestant Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Decongestant Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Decongestant Sales by Type
  6. 5.2.1 Global Decongestant Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Decongestant Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Decongestant Sales Market Share by Type (2021-2032)
  9. 5.3 Global Decongestant Price by Type
6 Decongestant Market by Application
  1. 6.1 Global Decongestant Revenue by Application
  2. 6.1.1 Global Decongestant Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Decongestant Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Decongestant Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Decongestant Sales by Application
  6. 6.2.1 Global Decongestant Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Decongestant Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Decongestant Sales Market Share by Application (2021-2032)
  9. 6.3 Global Decongestant Price by Application
7 Company Profiles
  1. 7.1 Teva Pharmaceutical Industries Ltd.
  2. 7.1.1 Teva Pharmaceutical Industries Ltd. Company Information
  3. 7.1.2 Teva Pharmaceutical Industries Ltd. Business Overview
  4. 7.1.3 Teva Pharmaceutical Industries Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Teva Pharmaceutical Industries Ltd. Decongestant Product Portfolio
  6. 7.1.5 Teva Pharmaceutical Industries Ltd. Recent Developments
  7. 7.2 Novartis AG
  8. 7.2.1 Novartis AG Company Information
  9. 7.2.2 Novartis AG Business Overview
  10. 7.2.3 Novartis AG Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis AG Decongestant Product Portfolio
  12. 7.2.5 Novartis AG Recent Developments
  13. 7.3 Mylan N.V.
  14. 7.3.1 Mylan N.V. Company Information
  15. 7.3.2 Mylan N.V. Business Overview
  16. 7.3.3 Mylan N.V. Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Mylan N.V. Decongestant Product Portfolio
  18. 7.3.5 Mylan N.V. Recent Developments
  19. 7.4 Ranbaxy Laboratories Ltd.
  20. 7.4.1 Ranbaxy Laboratories Ltd. Company Information
  21. 7.4.2 Ranbaxy Laboratories Ltd. Business Overview
  22. 7.4.3 Ranbaxy Laboratories Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ranbaxy Laboratories Ltd. Decongestant Product Portfolio
  24. 7.4.5 Ranbaxy Laboratories Ltd. Recent Developments
  25. 7.5 Cipla Ltd.
  26. 7.5.1 Cipla Ltd. Company Information
  27. 7.5.2 Cipla Ltd. Business Overview
  28. 7.5.3 Cipla Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Cipla Ltd. Decongestant Product Portfolio
  30. 7.5.5 Cipla Ltd. Recent Developments
  31. 7.6 Beximco Pharmaceuticals Ltd.
  32. 7.6.1 Beximco Pharmaceuticals Ltd. Company Information
  33. 7.6.2 Beximco Pharmaceuticals Ltd. Business Overview
  34. 7.6.3 Beximco Pharmaceuticals Ltd. Decongestant Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Beximco Pharmaceuticals Ltd. Decongestant Product Portfolio
  36. 7.6.5 Beximco Pharmaceuticals Ltd. Recent Developments
8 North America
  1. 8.1 North America Decongestant Market Size by Type
  2. 8.1.1 North America Decongestant Revenue by Type (2021-2032)
  3. 8.1.2 North America Decongestant Sales by Type (2021-2032)
  4. 8.1.3 North America Decongestant Price by Type (2021-2032)
  5. 8.2 North America Decongestant Market Size by Application
  6. 8.2.1 North America Decongestant Revenue by Application (2021-2032)
  7. 8.2.2 North America Decongestant Sales by Application (2021-2032)
  8. 8.2.3 North America Decongestant Price by Application (2021-2032)
  9. 8.3 North America Decongestant Market Size by Country
  10. 8.3.1 North America Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Decongestant Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Decongestant Market Size by Type
  2. 9.1.1 Europe Decongestant Revenue by Type (2021-2032)
  3. 9.1.2 Europe Decongestant Sales by Type (2021-2032)
  4. 9.1.3 Europe Decongestant Price by Type (2021-2032)
  5. 9.2 Europe Decongestant Market Size by Application
  6. 9.2.1 Europe Decongestant Revenue by Application (2021-2032)
  7. 9.2.2 Europe Decongestant Sales by Application (2021-2032)
  8. 9.2.3 Europe Decongestant Price by Application (2021-2032)
  9. 9.3 Europe Decongestant Market Size by Country
  10. 9.3.1 Europe Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Decongestant Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
  18. 9.3.9 Nordic Countries
10 China
  1. 10.1 China Decongestant Market Size by Type
  2. 10.1.1 China Decongestant Revenue by Type (2021-2032)
  3. 10.1.2 China Decongestant Sales by Type (2021-2032)
  4. 10.1.3 China Decongestant Price by Type (2021-2032)
  5. 10.2 China Decongestant Market Size by Application
  6. 10.2.1 China Decongestant Revenue by Application (2021-2032)
  7. 10.2.2 China Decongestant Sales by Application (2021-2032)
  8. 10.2.3 China Decongestant Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Decongestant Market Size by Type
  2. 11.1.1 Asia Decongestant Revenue by Type (2021-2032)
  3. 11.1.2 Asia Decongestant Sales by Type (2021-2032)
  4. 11.1.3 Asia Decongestant Price by Type (2021-2032)
  5. 11.2 Asia Decongestant Market Size by Application
  6. 11.2.1 Asia Decongestant Revenue by Application (2021-2032)
  7. 11.2.2 Asia Decongestant Sales by Application (2021-2032)
  8. 11.2.3 Asia Decongestant Price by Application (2021-2032)
  9. 11.3 Asia Decongestant Market Size by Country
  10. 11.3.1 Asia Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Decongestant Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Decongestant Market Size by Type
  2. 12.1.1 SAMEA Decongestant Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Decongestant Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Decongestant Price by Type (2021-2032)
  5. 12.2 SAMEA Decongestant Market Size by Application
  6. 12.2.1 SAMEA Decongestant Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Decongestant Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Decongestant Price by Application (2021-2032)
  9. 12.3 SAMEA Decongestant Market Size by Country
  10. 12.3.1 SAMEA Decongestant Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Decongestant Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Decongestant Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Decongestant Value Chain Analysis
  2. 13.1.1 Decongestant Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Decongestant Production Mode & Process
  6. 13.2 Decongestant Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Decongestant Distributors
  9. 13.2.3 Decongestant Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst